Fosun May Acquire Australian Hospital Operator in $5 Billion Deal

Fosun Pharma is in the hunt to acquire Australia's Healthscope, a hospital and pathology company owned by two US private equity firms, TPG and Carlyle Group. The deal is significant: Healthscope could draw bids as high as $5 billion. Earlier this week, Fosun and TPG teamed up to buy China hospital operator Chindex for $434 million. Fosun’s parent, the conglomerate Fosun International, has been busy acquiring ex-China investments of late. More details.... Stock Symbols: (SHA: 600196; HK: 2196) (NYSE: CG) Share this with colleagues: // //